Company Information

CIN
Status
Date of Incorporation
22 January 2002
Classes
Listing Status
Unlisted
Type
State
Bangalore
ROC
ROC Bangalore
Industry
Research And Experimental Development On Natural Sciences And Engineering
Sub Category
Non-govt company
Last Balance Sheet
31 March 2023
Last Annual Meeting
27 September 2023
Paid Up Capital
22,294,000
Authorised Capital
40,000,000

Directors

Narayanan Vaghul
Narayanan Vaghul
Director
for about 22 years
William J Rutter
William J Rutter
Director
for about 22 years
Anurag Bagaria
Anurag Bagaria
Director/Designated Partner
for over 1 year
Sumit Bagaria
Sumit Bagaria
Director/Designated Partner
for over 1 year

Past Directors

Ashok Sekhar Ganguly
Ashok Sekhar Ganguly
Director
almost 23 years ago

Trademarks

Hemogenomics Hemogenomics

[Class : 5] Pharmaceutical, Veterinary And Sanitary Substances Infants And Invalid Foods, Plasters Material For Bandaging Etc

Hemoinformatics Hemogenomics

[Class : 10] Surgical, Medical, Dental And Veterinary Instruments And Apparatus.

Hemoinformatics Hemogenomics

[Class : 5] Pharmaceutical, Veterinary And Sanitary Substances Infants And Invalid Foods, Plasters Material For Bandaging Etc

Hemogenomics Hemogenomics

[Class : 10] Surgical, Medical, Dental And Veterinary Instruments And Appartus.

Hemogenomics Hemogenomics

[Class : 35] Wholesale, Retail, Onlinesale, Export, Import Of Healthcare, Medical And Surgical Equipments.

Hemogenomics Hemogenomics

[Class : 37] Installation, Maintainence, Repair And Service Of Medical, Surgical And Healthcare Equipments

Charges

12 Crore
02 March 2016
Citi Bank N.a.
5 Crore
11 January 2012
Citi Bank N.a.
7 Crore
11 January 2012
Citi Bank N.a.
0
02 March 2016
Citi Bank N.a.
0
11 January 2012
Citi Bank N.a.
0
02 March 2016
Citi Bank N.a.
0
11 January 2012
Citi Bank N.a.
0
02 March 2016
Citi Bank N.a.
0

Documents

Company CSR policy as per section 135(4)-03122020
List of share holders, debenture holders;-03122020
Details of other Entity(s)-03122020
Copy of MGT-8-03122020
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-03122020
Details of salient features and justifications for entering into Contracts/Arrangements/Transactions with related parties as per section 188 (1) - Form AOC - 2-03122020
Directors report as per section 134(3)-03122020
Form MGT-7-03122020_signed
Form AOC-4-03122020_signed
Form DPT-3-01082020-signed
List of share holders, debenture holders;-21112019
Copy of MGT-8-21112019
Form MGT-7-21112019_signed
Form AOC-4-16112019_signed
Directors report as per section 134(3)-25102019
Company CSR policy as per section 135(4)-25102019
Optional Attachment-(1)-25102019
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-25102019
Details of other Entity(s)-25102019
Details of salient features and justifications for entering into Contracts/Arrangements/Transactions with related parties as per section 188 (1) - Form AOC - 2-25102019

Frequently Asked Questions

When was the Hemogenomics private limited incorporated?

The Hemogenomics private limited was incorporated with ROC on 22 January 2002 as .

Where has the Hemogenomics private limited been incorporated?

The company was incorporated in Bangalore with registration number 030032.

What is the E-filing status of the company?

The status of Hemogenomics private limited is Active.

Number of Key Management personnel of the Hemogenomics private limited?

The company has 5 key management personnel in the company.

Who are the directors of the Hemogenomics private limited?

The appointed directors in the company are:

  • Narayanan vaghul
  • Ashok sekhar ganguly
  • Anurag bagaria
  • Sumit bagaria
  • William j rutter